Study of platelet aggregation in acute coronary syndrome with special reference to metabolic syndrome
{{output}}
Background/context: Antiplatelet drug resistance increases the risk of adverse events like stent thrombosis in acute coronary syndrome (ACS). Metabolic syndrome (MS) is a prothrombotic state and presence of MS further increases t... ...
